3-hydroxykynurenine has been researched along with Nodding Syndrome in 1 studies
3-hydroxykynurenine: RN given refers to cpd without isomeric designation
3-hydroxykynurenine : A hydroxykynurenine that is kynurenine substituted by a hydroxy group at position 3.
hydroxykynurenine : A hydroxy-amino acid that is kynurenine substituted by a single hydroxy group at unspecified position. A "closed" class.
Nodding Syndrome: Unexplained neurologic condition characterized by episodes of atonic seizures, convulsions or staring spells with further cognitive decline.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We therefore explored vitamin B6 deficiency and resulting high 3-hydroxykynurenine (3-HK) levels as risk factor for nodding syndrome in Northern Uganda." | 5.43 | Reduced plasma concentrations of vitamin B6 and increased plasma concentrations of the neurotoxin 3-hydroxykynurenine are associated with nodding syndrome: a case control study in Gulu and Amuru districts, Northern Uganda. ( Arony, DA; Bodo, B; Moi, KL; Obol, JH; Odida, M; Odong, PO; Wanyama, R, 2016) |
| "Nodding syndrome was first reported in Uganda in 2003 among internally displaced populations." | 5.43 | Reduced plasma concentrations of vitamin B6 and increased plasma concentrations of the neurotoxin 3-hydroxykynurenine are associated with nodding syndrome: a case control study in Gulu and Amuru districts, Northern Uganda. ( Arony, DA; Bodo, B; Moi, KL; Obol, JH; Odida, M; Odong, PO; Wanyama, R, 2016) |
| "We therefore explored vitamin B6 deficiency and resulting high 3-hydroxykynurenine (3-HK) levels as risk factor for nodding syndrome in Northern Uganda." | 1.43 | Reduced plasma concentrations of vitamin B6 and increased plasma concentrations of the neurotoxin 3-hydroxykynurenine are associated with nodding syndrome: a case control study in Gulu and Amuru districts, Northern Uganda. ( Arony, DA; Bodo, B; Moi, KL; Obol, JH; Odida, M; Odong, PO; Wanyama, R, 2016) |
| "Nodding syndrome was first reported in Uganda in 2003 among internally displaced populations." | 1.43 | Reduced plasma concentrations of vitamin B6 and increased plasma concentrations of the neurotoxin 3-hydroxykynurenine are associated with nodding syndrome: a case control study in Gulu and Amuru districts, Northern Uganda. ( Arony, DA; Bodo, B; Moi, KL; Obol, JH; Odida, M; Odong, PO; Wanyama, R, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Obol, JH | 1 |
| Arony, DA | 1 |
| Wanyama, R | 1 |
| Moi, KL | 1 |
| Bodo, B | 1 |
| Odong, PO | 1 |
| Odida, M | 1 |
1 other study available for 3-hydroxykynurenine and Nodding Syndrome
| Article | Year |
|---|---|
Reduced plasma concentrations of vitamin B6 and increased plasma concentrations of the neurotoxin 3-hydroxykynurenine are associated with nodding syndrome: a case control study in Gulu and Amuru districts, Northern Uganda.
Topics: Adolescent; Case-Control Studies; Child; Child, Preschool; Female; Humans; Kynurenine; Logistic Mode | 2016 |